EBOS Group Limited/Announcement
EBOS Group Limited logo

Notice of change of interests in MedAdvisor

Substantial Holder Notice15 October 2019EBOHealthcare

Form 604
Corporations Act 2001

Section 671B


Notice of change of interests of substantial holder


To Company Name/Scheme MedAdvisor Limited


ACN/ARSN

ACN 145 327 617


1. Details of substantial holder (1)

Name


The following persons:

• EBOS Group Limited ("EBOS"), EBOS PH Pty Ltd ("EBOS PH") and each of the parties listed in Annexure 'A'

• Sybos Holdings Pte Limited and the Zuellig Group Incorporated (together "Zuellig") and related bodies,

(the foregoing persons collectively being the "Substantial Holders")


ACN/ARSN (if applicable)


There was a change in the interests of the

substantial holder on 11/10/2019

The previous notice was given to the company on 25/10/2017

The previous notice was dated 25/10/2017



2. Previous and present voting power


The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a

relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:


Class of securities (4)

Previous notice Present notice

Person’s votes Voting power (5) Person’s votes Voting power (5)


Fully paid ordinary shares

("Shares")

185,217,391

14.10% (based on

1,313,277,982 Shares on

issue)

185,217,391

10.78% (based on

1,718,569,088 Shares

on issue)




3. Changes in relevant interests


Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or

scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:


Date of

change

Person

whose

relevant

interest

changed

Nature of

change (6)

Consideration

given in

relation

to change (7)

Class and

number of

securities

affected

Person’s votes

affected


11/10/2019

Substantial

Holders

Decrease in relevant interest as a result

of 340,000,000 Shares issued, further

details of which are set out in the

Appendix 3B lodged with the ASX by

MedAdvisor Limited on 11 October 2019

("October 2019 Appendix 3B").

N/A 185,217,391 Shares 185,217,391

11/10/2019

Substantial

Holders

Decrease in relevant interest as a result

of 2,500,000 Shares issued, further

deta

ils of which are set out in the October

2019 Appendix 3B.

N/A 185,217,391 Shares 185,217,391

11/10/2019
Substantial

Holders

Decrease in relevant interest as a result

of 2,686,666 Shares issued, further

details of which are set out in the October

2019 Appendix 3B.

N/A 185,217,391 Shares 185,217,391

30/07/2019

Substantial

Holders

Decrease in relevant interest as a result

of 1,470,000 Shares issued, further

details of which are set out in the

Appendix 3B lodged with the ASX by

MedAdvisor Limited on 30 July 2019.

N/A 185,217,391 Shares 185,217,391

17/06/2019

Substantial

Holders

Decrease in relevant interest as a result

of 1,299,999 Shares issued, further

details of which are set out in the

Appendix 3B lodged with the ASX by

MedAdvisor Limited on 17 June 2019.

N/A 185,217,391 Shares 185,217,391

22/05/2019

Substantial

Holders

Decrease in relevant interest as a result

of 2,653,332 Shares issued, further

details of which are set out in the

Appendix 3B lodged with the ASX by

MedAdvisor Limited on 22 May 2019

("May 2019 Appendix 3B").

N/A 185,217,391 Shares 185,217,391

22/05/2019

Substantial

Holders

Decrease in relevant interest as a result

of 5,000,000 Shares issued, further

details of which are set out in the May

2019 Appendix 3B.

N/A 185,217,391 Shares 185,217,391

29/03/2019

Substantial

Holders

Decrease in relevant interest as a result

of 2,250,000 Shares issued, further

details of which are set out in the

Appendix 3B lodged with the ASX by

MedAdvisor Limited on 8 February 2019

("March 2019 Appendix 3B").

N/A 185,217,391 Shares 185,217,391

29/03/2019

Substantial

Holders

Decrease in relevant interest as a result

of 194,445 Shares, further details of

which are set out in the March 2019

Appendix 3B.

N/A 185,217,391 Shares 185,217,391

08/02/2019

Substantial

Holders

Decrease in relevant interest as a result

of 22,500,000 Shares issued, further

details of which are set out in the

Appendix 3B lodged with the ASX by

MedAdvisor Limited on 8 February 2019

("February 2019 Appendix 3B").

N/A 185,217,391 Shares 185,217,391

08/02/2019

Substantial

Holders

Decrease in relevant interest as a result

of 4,886,664 Shares issued, further

details of which are set out in the

February 2019 Appendix 3B.

N/A 185,217,391 Shares 185,217,391

12/11/2018
Substantial

Holders

Decrease in relevant interest as a result

of 10,000,000 Shares issued, further

details of which are set out in the

Appendix 3B lodged with the ASX by

MedAdvisor Limited on 12 November

2018.

N/A 185,217,391 Shares 185,217,391

24/08/2018

Substantial

Holders

Decrease in relevant interest as a result

of 5,200,000 Shares issued, further

details of which are set out in the

Appendix 3B lodged with the ASX by

MedAdvisor Limited on 24 August 2018.

N/A 185,217,391 Shares 185,217,391

16/04/2018

Substantial

Holders

Decrease in relevant interest as a result

of 3,650,000 Shares, further details of

which are set out in the Appendix 3B

lodged with the ASX by MedAdvisor

Limited on 16 April 2018 ("April 2018

Appendix 3B").

N/A 185,217,391 Shares 185,217,391

16/04/2018

Substantial

Holders

Decrease in relevant interest as a result

of 1,000,000 Shares issued, further

details of which are set out in the April

2018 Appendix 3B.

N/A 185,217,391 Shares 185,217,391

4.Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

H

older of

relevant

interest

Registered

holder of

securities

Person

entitled

to be

registered

Nature of

relevant

interest (6)

Class and

number of

securities

Person’s

votes

EBOS PH EBOS PH EBOS PH

Registered holder of securities.

1

85,217,391

Shares

185,217,391

EBOS EBOS PH EBOS PH

Deemed under section 608(3)(b) of the

Corporations Act 2001 (Cth) to have a

relevant interest in the Shares in which

EBOS has a relevant interest

185,217,391

Shares

185,217,391

Zuellig EBOS PH EBOS PH

Deemed under section 608(3)(a) of the

Corporations Act 2001 (Cth) to have a

relevant interest in the Shares in which

EBOS has a relevant interest

185,217,391

Shares

185,217,391

5.Changes in association
The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in

relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if

applicable)

Nature of association

Nature's Recipe Pet Foods (NZ) Ltd Ceased to be an associate

Warner and Webster Pty. Limited Became an associate

W & W Management Services Pty Ltd Became an associate

Mega Save Management Pty Ltd Became an associate

CC Pharmacy Investments Pty Ltd Became an associate

CC Pharmacy Management Pty Ltd Became an associate

PBA Finance No. 1 Pty Ltd Became an associate

Collaboration Medical Clinics Pty Ltd Became an associate

BFCMC Pty Ltd Became an associate

Ventura Health Pty Ltd Became an associate

Cincotta Holding Company Pty Ltd Became an associate

You Save Management Pty Ltd Became an associate

CC Pharmacy Promotions Pty Limited Became an associate

Healthcare Supply Partners Pty Ltd Became an associate

EBOS Medical Devices NZ Limited Became an associate

National Surgical Pty Ltd Became an associate

EBOS Medical Devices Australia Pty Ltd Became an associate

LMT Surgical Pty Ltd Became an associate

Shanghai EBOS Business Management

Co. Ltd

Became an associate

6. Addresses

The addresses of persons named in this form are as follows:

Name Address

EBOS PH, EBOS and each of the

parties listed in Annexure 'A'

Level 7, 737 Bourke Street, Docklands, Victoria 3008

Zuellig and related bodies 2003-2006 Shui On Centre, 6-8 Harbour Road, Wanchai, Hong Kong

Signature
Signed on behalf of the Substantial Holders

print name John Cullity capacity Authorised Signatory

sign here

Date 15 / 10 / 2019

DIRECTIONS

(1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and

trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar,

they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members

is clearly set out in paragraph 6 of the form.

(2) See the definition of "associate" in section 9 of the Corporations Act 2001.

(3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

(4) The voting shares of a company constitute one class unless divided into separate classes.

(5) The person’s votes divided by the total votes in the body corporate or scheme multiplied by 100.

(6) Include details of:

(a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy

of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract,

scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

(b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the

securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

(7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may,

become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a

contingency. Details must be included on any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they

are not paid directly to the person from whom the relevant interest was acquired.

(8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write “unknown’”.

(9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.

Annexure A
This is Annexure "A" of 1 page referred to in the accompanying Form 604.

Signature on behalf of the Substantial Holders

pri nt name John Cullity capacity Authorised Signatory

sign here

Date 15 / 10 / 2019

Pet Care Holdings Australia Pty Limited Terry White Group Limited

EBOS Group Australia Pty Limited Developing People Pty Ltd

EBOS Health & Science Pty Limited Chemmart Holdings Pty Limited

PRNZ Limited TW&CM Pty Ltd

Pharmacy Retailing NZ Limited TWC IP Pty Ltd

Pet Care Distributors Pty Limited PBA Wholesale Pty Ltd

Masterpet Corporation Limited VIM Health Pty Ltd

Masterpet Australia Pty Limited PBA Finance No. 1 Pty Ltd

Botany Bay Imports Exports Pty Limited PBA Finance No. 2 Pty Ltd

Aristopet Pty Ltd Chem Plus Pty Ltd

Richard Thomson Pty Ltd Pharmacy Brands Australia Pty Ltd

Pets International Pty Ltd VIM Health IP Pty Ltd

Beaphar Pty Ltd Tony Ferguson Weight Management Pty Ltd

Black Hawk Premium Pet Care Pty Limited Lite Living Pty Ltd

Shanghai EBOS Business Management Co. Ltd Collaboration Medical Clinics Pty Ltd

Masterpet Logistics Pty Ltd BFCMC Pty Ltd

Vitapet Corporation Pty Ltd Alchemy Holdings Pty Limited

EAHPL Pty Limited Alchemy Sub-Holdings Pty Ltd

ZHHA Pty Ltd HPS Holdings Group (Aust) Pty Ltd

ZAP Services Pty Ltd HPS Hospitals Pty Ltd

Symbion Pty Ltd HPS Corrections Pty Ltd

Intellipharm Pty Ltd HPS Services Pty Ltd

Clinect Pty Ltd Hospharm Pty Ltd

Lyppard Australia Pty Ltd HPS IVF Pty Ltd

DoseAid Pty Limited HPS Finance Pty Ltd

Symbion Pharmacy Services Trade Receivables Trust HPS Brands Pty Ltd

Clinect NZ Pty Ltd Ventura Health Pty Ltd

Endeavour Consumer Health Limited Cincotta Holding Company Pty Ltd

Nexus Australasia Pty Limited You Save Management Pty Ltd

Endeavour CH Pty Ltd CC Pharmacy Promotions Pty Limited

ACN 618 208 969 Pty Ltd Healthcare Supply Partners Pty Ltd

Warner and Webster Pty. Limited EBOS Medical Devices NZ Limited

W & W Management Services Pty Ltd National Surgical Pty Ltd

Mega Save Management Pty Ltd EBOS Medical Devices Australia Pty Ltd

CC Pharmacy Investments Pty Ltd LMT Surgical Pty Ltd

CC Pharmacy Management Pty Ltd

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.